IHM
Iguana Healthcare Management Portfolio holdings
AUM
$133M
This Quarter Return
+13.9%
1 Year Return
+45.66%
3 Year Return
+127.07%
5 Year Return
–
10 Year Return
–
AUM
$260M
AUM Growth
+$260M
(+22%)
Cap. Flow
+$35.5M
Cap. Flow
% of AUM
13.61%
Top 10 Holdings %
Top 10 Hldgs %
50.95%
Holding
90
New
20
Increased
23
Reduced
11
Closed
22
Top Buys
| 1 |
Cigna
CI
|
$13.9M |
| 2 |
CELG
Celgene Corp
CELG
|
$13.2M |
| 3 |
Baxter International
BAX
|
$12.4M |
| 4 |
Viatris
VTRS
|
$6.22M |
| 5 |
OMED
OncoMed Pharmaceuticals, Inc.
OMED
|
$6.2M |
Top Sells
| 1 |
Elevance Health
ELV
|
$14M |
| 2 |
Pfizer
PFE
|
$9.42M |
| 3 |
Edwards Lifesciences
EW
|
$8.53M |
| 4 |
McKesson
MCK
|
$5.55M |
| 5 |
Medtronic
MDT
|
$5.02M |
Sector Composition
| 1 | Healthcare | 91.33% |
| 2 | Financials | 2.08% |
| 3 | Consumer Staples | 0.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CELG
1
DELISTED
Celgene Corp
CELG
| $24M | 7.88% |
200,000
+110,000
| +122% | +$13.2M |
|
|
2
Cigna
CI
$80.3B
| $19.8M | 6.5% |
135,000
+95,000
| +238% | +$13.9M |
|
3
Amgen
AMGN
$155B
| $16.2M | 5.34% |
100,000
+35,000
| +54% | +$5.68M |
|
4
Ultragenyx Pharmaceutical
RARE
$2.89B
| $12.9M | 4.24% |
115,000
+5,000
| +5% | +$561K |
|
|
5
Baxter International
BAX
$12.7B
| $12.4M | 4.08% |
+325,000
| New | +$12.4M |
|
|
6
Viatris
VTRS
$12.3B
| $12.2M | 4% |
225,000
+115,000
| +105% | +$6.22M |
|
7
Teva Pharmaceuticals
TEVA
$21.1B
| $9.85M | 3.24% |
150,000
+50,000
| +50% | +$3.28M |
|
8
Gilead Sciences
GILD
$140B
| $9.11M | 3% |
90,000
-10,000
| -10% | -$1.01M |
|
|
OMED
9
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $9.02M | 2.97% |
400,000
+275,000
| +220% | +$6.2M |
|
|
XLRN
10
DELISTED
Acceleron Pharma Inc.
XLRN
| $7.31M | 2.41% |
150,000
+40,000
| +36% | +$1.95M |
|
11
Biogen
BIIB
$19.4B
| $6.13M | 2.02% |
20,000
-10,000
| -33% | -$3.06M |
|
|
AET
12
DELISTED
Aetna Inc
AET
| $5.41M | 1.78% |
50,000
| – | – |
|
13
Merck
MRK
$210B
| $5.28M | 1.74% |
+100,000
| New | +$5.28M |
|
|
ESRX
14
DELISTED
Express Scripts Holding Company
ESRX
| $5.25M | 1.73% |
60,000
-15,000
| -20% | -$1.31M |
|
|
ENDP
15
DELISTED
Endo International plc
ENDP
| $4.59M | 1.51% |
75,000
+5,000
| +7% | +$306K |
|
|
ADAP
16
Adaptimmune Therapeutics
ADAP
$15.6M
| $4.26M | 1.4% |
353,161
+278,161
| +371% | +$3.35M |
|
|
MDRX
17
DELISTED
Veradigm Inc. Common Stock
MDRX
| $4.23M | 1.39% |
275,000
+15,000
| +6% | +$231K |
|
|
GWPH
18
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $4.21M | 1.39% |
60,687
+20,687
| +52% | +$1.44M |
|
19
Sarepta Therapeutics
SRPT
$1.78B
| $3.86M | 1.27% |
+100,000
| New | +$3.86M |
|
20
Pacira BioSciences
PCRX
$1.2B
| $3.84M | 1.26% |
+50,000
| New | +$3.84M |
|
|
AXDX
21
DELISTED
Accelerate Diagnostics
AXDX
| $3.76M | 1.24% |
175,000
+25,000
| +17% | +$537K |
|
22
Cytokinetics
CYTK
$4.23B
| $3.66M | 1.2% |
+350,000
| New | +$3.66M |
|
|
GBT
23
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $3.56M | 1.17% |
110,000
+45,000
| +69% | +$1.45M |
|
|
HTWR
24
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| $3.53M | 1.16% |
+70,000
| New | +$3.53M |
|
|
EVHC
25
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $3.25M | 1.07% |
+125,000
| New | +$3.25M |
|